First NxStageÃ‚® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
LAWRENCE, Mass., Dec. 16, 2010 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their seven-year anniversary of home hemodialysis treatment with the NxStage® System One™, the only hemodialysis machine cleared by the FDA for home use. Each of these patients continues to experience the improved health and quality of life benefits possible with more frequent home hemodialysis using the System One.
As early adopters of daily home hemodialysis with the NxStage System One, each of the patients arrived at the decision to try NxStage at various stages in his treatment for end stage renal disease (ESRD). These patients--Craig, Carl, and Everette--began treatment with the NxStage System One in December, 2003 as part of NxStage's groundbreaking clinical trial for its home indication.
Everette had been undergoing in-center dialysis treatments when he learned about daily home hemodialysis with NxStage. "For the past seven years, the NxStage System One has given me the freedom to live my life closer to the way I want to live it and allowed me to dedicate more time to my hobbies and business dreams," he said. "Thanks in part to NxStage and dialyzing more frequently, I feel more healthy and active. I've come off several blood pressure medications and play basketball twice a week while spearheading my online clothing store."
"This is a tremendous milestone not only for these patients, but also for all of our patients, prescribing nephrologists, partners and employees," stated Jeffrey H. Burbank, founder and CEO of NxStage Medical, Inc. "We are extremely gratified to see these patients thriving and are excited to expand access to the life changing benefits possible with more frequent home hemodialysis using the System One to a gro